4//SEC Filing
Beebe Katherine 4
Accession 0000921895-23-002393
CIK 0000910267other
Filed
Oct 25, 8:00 PM ET
Accepted
Oct 26, 4:25 PM ET
Size
4.9 KB
Accession
0000921895-23-002393
Insider Transaction Report
Form 4
Beebe Katherine
Chief Scientific Officer
Transactions
- Award
Common Stock
2023-10-25+16,250→ 66,250 total
Footnotes (1)
- [F1]The shares reported in this transaction represent Unrestricted Stock Awards pursuant to the Issuer's Fourth Amended and Restated 2015 Omnibus Equity Incentive Plan that vested immediately on the date of grant.
Documents
Issuer
TITAN PHARMACEUTICALS INC
CIK 0000910267
Entity typeother
Related Parties
1- filerCIK 0001768867
Filing Metadata
- Form type
- 4
- Filed
- Oct 25, 8:00 PM ET
- Accepted
- Oct 26, 4:25 PM ET
- Size
- 4.9 KB